Chronic inflammatory processes play an important role in the pathogenesis of Alzheimer's disease (AD) and other neurodegenerative diseases. 1) In particular, AD is characterized by neuroinflammatory changes and increased free radicals, as well classic neuropathological features such as amyloid plaques, neuronal loss, and neurofibrillary tangles.2) For example, clumps of activated microglias and reactive astrocytes appear in the vicinity of senile plaques.
2)Microglial cells play major roles in host defense and tissue repair in the central nervous system (CNS).3) Microglial cells are activated in response to brain injury and exposure to lipopolysaccharide (LPS), interferon (IFN)-g, or b-amyloid. 4,5) Once chronically activated, microglial cells produce a variety of proinflammatory mediators and potentially neurotoxic compounds such as interleukin (IL)-1b, IL-6, tumor necrosis factor (TNF)-a, reactive oxygen species (ROS) and nitric oxide (NO). These have the deleterious effects on brain injuries and neurodegenerative diseases. 6,7) Macelignan, isolated from Myristica fragrans HOUTT, has been reported to exhibit free-radical scavenging and prostaglandin inhibitory properties. 7) Studies using neuronal cells and primary microglial cells have demonstrated that macelignan suppresses NO production by inhibiting inducible nitric oxide (iNOS) expression at the transcriptional level; it also significantly suppresses the production of proinflammatory cytokine TNF-a and IL-6.8) The anti-inflammatory effects of macelignan were also evaluated using animal model with a chronic infusion of LPS, one of wellcharacterized animal models incorporating important neuropathological features seen in AD. Oral administration of macelignan reduces hippocampal microglial activation and the impairments of spatial memory that are induced by chronic infusions of LPS into the fourth ventricle in rat brains.9) These results indicate that macelignan possesses therapeutic potential against neurodegenerative diseases that involve neuroinflammation. 8,9) However, the protecting molecular mechanisms of its actions have not yet been studied.It has recently been suggested that mitogen-activated protein kinases (MAPKs) play a role in the inflammation associated with the formation of plaques, eventually leading to AD.10) The present study investigates whether macelignan has anti-inflammatory effects through the suppression of the LPS-induced activation of nuclear factor kappa B (NF-kB) by blocking the degradation of inhibitory-kappa B (IkBa) and the phosphorylations of MAPK. To determine the involvement of the MAPK signal pathway and NF-kB in mediating the anti-inflammatory effects of macelignan, the activities of MAPKs such as p38, extracellular-signal-regulated kinase1/2 (ERK1/2), and c-Jun NH 2 -terminal kinase (JNK) were measured in response to treatments of macelignan in LPS-stimulated BV-2 microglial cells. IBST, Konkuk University; Seoul 143-729, South Korea: and c Department of Biotechnology, Yonsei University; Seoul 120-752, South Korea. Re...